IMVT: Immunovant, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 4,117.31
Enterprise Value ($M) 3,644.37
Book Value ($M) 449.05
Book Value / Share 3.06
Price / Book 9.17
NCAV ($M) 440.72
NCAV / Share 3.00
Price / NCAV 9.34

Profitability (mra)
Return on Invested Capital (ROIC) -0.72
Return on Assets (ROA) -1.11
Return on Equity (ROE) -1.28

Liquidity (mrq)
Quick Ratio 7.61
Current Ratio 7.61

Balance Sheet (mrq) ($M)
Current Assets 507.37
Assets 515.71
Liabilities 66.65
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -270.21
Net Income -259.34
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Non Redeemable Common Stock Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -214.23
Cash from Investing -0.36
Cash from Financing 472.43

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
5 days ago 13G/A Fmr Llc 8.56 59.19
02-14 13G/A Deep Track Capital, LP 0.69 -89.70

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-02-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-15 319,275 1,391,419 22.95
2024-11-14 195,691 892,502 21.93
2024-11-13 109,716 560,343 19.58
2024-11-12 191,241 788,453 24.26
2024-11-11 78,074 417,573 18.70

(click for more detail)

Similar Companies
IFRX – InflaRx N.V. IGMS – IGM Biosciences, Inc.
IMUX – Immunic, Inc. INBX – Inhibrx Biosciences, Inc.
INDV – Indivior PLC


Financial data and stock pages provided by
Fintel.io